Jul 25, 2012 - Coartem Malaria Drugs
Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz, two companies with a rich and diverse corporate history. Throughout the years, Novartis and its predecessor companies have discovered and developed many innovative products for patients and consumers worldwide.
Novartis strives to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life.
Novartis is committed to working with national governments to prevent and prosecute the production or sale of counterfeit medicines. This is a longstanding commitment that is consistent with our overall concern for the health and safety of patients who use our products, as well as for the public health generally. The integrity and reputation of the Novartis brand depends upon on our ability to assure patients that products which bear our name are, in fact, our products, backed by superior, unwavering
standards of quality, safety and efficacy
 |
